<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
For Registration of Certain Classes of Securities
Pursuant to Section 12(b) or (g) of the
Securities Exchange Act of 1934
ABT GLOBAL PHARMACEUTICAL CORP.
- ---------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
California 33-07640125
- ------------------------------------------- -----------------------
(State of incorporation (I.R.S. Employer
or organization) Identification No.)
5 Park Plaza, Suite 770, Irvine, California 92714
- -------------------------------------------------- -----------------------
(Address of principal executive offices) (Zip Code)
Securities to be Registered Pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
------------------- ------------------------------
- ----------------------------------- --------------------------------------
- ----------------------------------- --------------------------------------
- ----------------------------------- --------------------------------------
Securities to be Registered Pursuant to Section 12(g) of the Act:
Common Stock, without par value
- ---------------------------------------------------------------------------
(Title of Class)
- ---------------------------------------------------------------------------
(Title of Class)
<PAGE>
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
-------------------------------------------------------
Description of Securities./1/
ITEM 2. EXHIBITS.
--------
The Common Stock of the Company is to be registered on the Nasdaq National
Market, on which no other securities of the Company are registered. The
following exhibits required in accordance with Part II to the Instruction as to
Exhibits on Form 8-A have been duly filed with Nasdaq.
1.1 This Registration Statement of the Company on Form 8-A filed
pursuant to Section 12(g) of the Act.
1.2 Registration of the Company on Form SB-2 (File No. 333-4912-LA), as
amended by pre-effective Amendments Nos. 1, and 2 thereto./2/
4.1 Articles of Incorporation of the Company./3/
4.2 Bylaws of the Company./4/
5 Specimen Common Stock certificate./5/
6 Annual Report of the Company, for the fiscal year ended March 31,
1996./6/
- -----------------
/1/ Incorporated herein by reference to "Description of Securities" in the
Company's Registration Statement on Form SB-2 (File No. 333-4912-LA), as
amended by pre-effective Amendments Nos. 1 and 2 thereto (as so amended,
the "Registration Statement"), filed with the Securities and Exchange
Commission under the Securities Act of 1933.
/2/ Filed with the Registration Statement on Form 8-A filed with Nasdaq.
/3/ Incorporated herein by reference to Exhibit 3.1 to the Registration
Statement.
/4/ Incorporated herein by reference to Exhibit 3.2 to the Registration
Statement.
/5/ Incorporated herein by reference to Exhibit 4.2 of the Registration
Statement.
/6/ Included in Exhibit 1.2.
Page 2 of 3
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act of
1934, the registrant has duly caused this Registration Statement to be signed on
its behalf by the undersigned, thereunto duly authorized.
Date: August 5, 1996 ABT GLOBAL PHARMACEUTICAL CORP.
--------
By: /s/ Elliot P. Friedman
---------------------------------
Elliot P. Friedman,
President
Page 3 of 3
